Experimental basis of cancer combination chemotherapy with retinoids, cytokines, 1,25-dihydroxyvitamin D3, and analogs
- 1 December 1994
- journal article
- review article
- Published by Wiley in Journal of Cellular Biochemistry
- Vol. 56 (4) , 427-435
- https://doi.org/10.1002/jcb.240560402
Abstract
Retinoids, cytokines as well as 1,25‐dihydroxyvitamin D3 [1,25(OH)2D3] and analogs possess properties known to contribute potentially to cancer chemopreventive and chemotherapeutic effects. They induce cell differentiation, inhibit cell prolifeation, suppress expression of viral oncogenes, and inhibit angiogenesis nexessary for tumor growth. Since clinical combination chemotherapy of cytotoxic agents has proven superior to monotherapy, This moddality might also be useful for other classes of antitumor drugs. A series of retinoids, such as all‐trans‐, 13‐cis‐, 9‐cis retinoic acid, and acitreti, cytokines, 1,25(OH)2D3, and analogs have been investigated in mocdel systems of defferentiation, proliferation, viral oncogenes, and angiogenesis. The three classes of compounds have common effects but nevertheless show a variance depending on the particular representative of each class. Combination of compounds of the different classes led in the various models to a hegher efficacy compared with the compounds given alone. Cytokines such as IFNα, IFNγ, G‐CSF, TNFα, IL‐1, and IL‐4 markedly potentiate the differentiation‐inducing effect of retinoids. Cytokines as well as retinoids combined with 1,25(OH)2D3 and analogs synergistically enhanced differentiation induction in human transformed hemopoietic cell lines. On a series of human transformed epithelial cell lines a panel of cytokies, such as IFNα, IFNβ, TNFα, TGFβ, and EGF acted synergistically with retinoies on inhibition of proliferation. This was also observed by combining retinoids with 1,25(OH)2D3 and analogs. Retinoids as well as interferons α and γ have the capacity to suppress the capacity to supperess the oncogene expression of human papilloma viruses which are involved in induction and growth of certain malignancies such as cervical cancer. All‐trans‐, 13‐cis‐, 9‐cis retinoic acid, and acitretin as well as IFNα inhinited the formation of newly formed blood vessels induced by injection of HPV harboring, tumorigenic cell lines into Balb/C mice. The combination of retinoids with IFNα was more efficacious in inhibition angiogenesis than a retinoid or IFNα given alone. Since there is evidence that cell differentiationl, cell proliferation, viral oncogene expression as well as angiogenesis play a role in tumor induction and/or progression of tumor growth, retinoids, cytokines, as well as 1,25(OH)2D3 and analogs may be useful in chemoprevention and chemotherapy of neoplasms. based on the superior effect of combinations compared with administration of single compounds of these three classes under experimental conditions there is hope that also clinical application of combination treatment might bring as a step forward in chemopreventio and chemotherapy of cancer. This has already been proven in a very limited number of very limited numberr of clinical trials.Keywords
This publication has 40 references indexed in Scilit:
- Modulation of Growth and Differentiation by Retinoids and CytokinesPublished by S. Karger AG ,2015
- Two nuclear signalling pathways for vitamin DNature, 1993
- Effects of synthetic vitamin d analogues on breast cancer cell proliferation in vivo and in vitroBiochemical Pharmacology, 1992
- Retinoids in cancer prevention and therapyAnnals of Oncology, 1992
- Inhibition of proliferation by retinoids, cytokines and their combination in four human transformed epithelial cell linesCancer Letters, 1992
- A Novel Vitamin D3Analog, 22-Oxa-1, 25- Dihydroxyvitamin D3, Inhibits the Growth of Human Breast Cancerin Vitroandin Vivowithout Causing Hypercalcemia*Endocrinology, 1991
- Novel growth regulatory factors and tumour angiogenesisEuropean Journal of Cancer and Clinical Oncology, 1991
- Effects of a novel vitamin D analogue MC 903 on cell proliferation and differentiation in vitro and on calcium metabolism in vivoBiochemical Pharmacology, 1988
- 1,25-Dihydroxyvitamin D3 inhibitory effect on the growth of two human breast cancer cell lines (MCF-7, BT-20)Journal of Steroid Biochemistry, 1986
- Combination Chemotherapy in the Treatment of Advanced Hodgkin's DiseaseAnnals of Internal Medicine, 1970